ICU Medical Financial Statements (ICUI)

ICU Medicalsmart-lab.ru %   2020 2021 2022 2022 2023   LTM ?
Report date 26.02.2021 25.02.2022 31.12.2022 27.02.2023 27.02.2024   07.05.2024
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 1 271 1 316 2 280 2 280 2 259   2 257
Operating Income, bln rub 41.8 52.4 -42.9 -8.70 39.7   10.2
EBITDA, bln rub ? 136.7 142.1 187.4 226.4 290.4   241.1
Net profit, bln rub ? 86.9 103.1 -154.5 -74.3 -29.7   -59.3
OCF, bln rub ? 222.8 267.5 -62.1 -62.1 166.2   170.7
CAPEX, bln rub ? 100.4 81.2 90.3 99.3 93.7   95.8
FCF, bln rub ? 122.4 186.4 -152.4 -161.5 72.5   74.9
Dividend payout, bln rub 0.000 0.000 0.000 0.000 0.000   0.000
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
OPEX, bln rub 325.9 350.2 740.7 701.3 670.1   699.2
Cost of production, bln rub 809.5 824.8 1 582 1 582 1 549   1 539
R&D, bln rub 42.9 47.5 93.0 93.0 85.3   87.4
Interest expenses, bln rub 1.75 0.858 66.4 66.4 135.3   107.8
Assets, bln rub 1 764 1 881 4 516 4 516 4 378   4 288
Net Assets, bln rub ? 1 502 1 616 2 090 2 090 2 123   2 068
Debt, bln rub 52.1 45.0 1 653 1 653 1 705   1 687
Cash, bln rub 410.8 567.2 213.0 213.0 254.7   251.4
Net debt, bln rub -358.6 -522.2 1 440 1 440 1 450   1 436
Ordinary share price, rub 214.5 237.3 157.5 157.5 99.7   100.1
Number of ordinary shares, mln 20.9 21.2 23.9 23.9 24.1   24.2
Market cap, bln rub 4 484 5 033 3 759 3 759 2 403   2 424
EV, bln rub ? 4 126 4 511 5 199 5 199 3 853   3 860
Book value, bln rub 1 272 1 384 -342 -342 -220   -228
EPS, rub ? 4.16 4.86 -6.47 -3.11 -1.23   -2.45
FCF/share, rub 5.85 8.79 -6.39 -6.76 3.01   3.09
BV/share, rub 60.8 65.3 -14.3 -14.3 -9.12   -9.43
EBITDA margin, % ? 10.8% 10.8% 8.22% 9.93% 12.9%   10.7%
Net margin, % ? 6.83% 7.84% -6.78% -3.26% -1.31%   -2.63%
FCF yield, % ? 2.73% 3.70% -4.06% -4.30% 3.02%   3.09%
ROE, % ? 5.78% 6.38% -7.39% -3.55% -1.40%   -2.87%
ROA, % ? 4.93% 5.48% -3.42% -1.65% -0.68%   -1.38%
P/E ? 51.6 48.8 -24.3 -50.6 -81.0   -40.9
P/FCF 36.6 27.0 -24.7 -23.3 33.1   32.3
P/S ? 3.53 3.82 1.65 1.65 1.06   1.07
P/BV ? 3.53 3.64 -11.0 -11.0 -10.9   -10.6
EV/EBITDA ? 30.2 31.7 27.7 23.0 13.3   16.0
Debt/EBITDA -2.62 -3.68 7.69 6.36 4.99   5.95
R&D/CAPEX, % 42.8% 58.5% 103.0% 93.6% 91.1%   91.3%
CAPEX/Revenue, % 7.90% 6.17% 3.96% 4.36% 4.15%   4.25%
ICU Medical shareholders